Last reviewed · How we verify
Comparable Placebo of drug
Comparable Placebo of drug is a Small molecule drug developed by Biomed Industries, Inc.. It is currently in Phase 3 development for Control arm in Phase 3 clinical trials (indication depends on the active drug being tested). Also known as: Placebo comparator.
A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.
A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect. Used for Control arm in Phase 3 clinical trials (indication depends on the active drug being tested).
At a glance
| Generic name | Comparable Placebo of drug |
|---|---|
| Also known as | Placebo comparator |
| Sponsor | Biomed Industries, Inc. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebos are inert substances used as controls in clinical trials to measure the true efficacy of an investigational drug by accounting for psychological and physiological responses to treatment expectation. In Phase 3 trials, placebos serve as the comparator arm to establish that the active drug performs better than the control condition. The placebo effect itself can involve real neurobiological changes driven by patient expectation and the clinical context.
Approved indications
- Control arm in Phase 3 clinical trials (indication depends on the active drug being tested)
Common side effects
Key clinical trials
- Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (PHASE2)
- Statins Against Bushfire Smoke (PHASE4)
- Investigation of the Effects of a Multispecies Probiotic Formulation on Perennial Allergic Rhinitis (NA)
- Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan (PHASE2)
- The Influence of Probiotics on Metabolome and Heart Rate Variability in Heart Failure of Structure Heart Disease (NA)
- Gut Health Enhancement by Eating Favourable Food (NA)
- A Causal Role for Voltage-gated Cav1.2 Calcium Channels in Mediating 5G FR1 Effects on Sleep-associated Brain Health in Humans (NA)
- CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Comparable Placebo of drug CI brief — competitive landscape report
- Comparable Placebo of drug updates RSS · CI watch RSS
- Biomed Industries, Inc. portfolio CI
Frequently asked questions about Comparable Placebo of drug
What is Comparable Placebo of drug?
How does Comparable Placebo of drug work?
What is Comparable Placebo of drug used for?
Who makes Comparable Placebo of drug?
Is Comparable Placebo of drug also known as anything else?
What development phase is Comparable Placebo of drug in?
Related
- Manufacturer: Biomed Industries, Inc. — full pipeline
- Indication: Drugs for Control arm in Phase 3 clinical trials (indication depends on the active drug being tested)
- Also known as: Placebo comparator
- Compare: Comparable Placebo of drug vs similar drugs
- Pricing: Comparable Placebo of drug cost, discount & access